Stay updated with breaking news from Technology Development Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Neil Bodie, CEO of Paradigm, will discuss Paradigm’s groundbreaking biological, virtual mask in his presentation, “A Breakthrough in SARS...
Los Angeles, CA (PRWEB) May 23, 2022 -- UCLA Technology Development Group (UCLA TDG) presents the Los Angeles Bioscience Ecosystem Summit 2022 (LABEST,
In sign of progress on key project pegged as its next big bet.
A report from The Information details the decision behind the years-long delay of Apple's headset and reveals a previously unreported feature:
New research indicates the novel gene editing technique base editing could be used as a one-time therapy to restore the production of T cells in patients born with the rare genetic immune disorder CD3 delta severe combined immunodeficiency. This condition, also known as CD3 delta SCID, is caused by a mutation in the CD3 delta gene, which produces a protein by the same name